Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지

Efficacy and Safety of Laser Surgery and Transurethral Resection of the Prostate for Treating Benign Prostate Hyperplasia: a Network Meta-analysis

  • Wang, Li (Department of Preventive Medicine, Shantou University Medical College) ;
  • Yu, Qiu-Yan (Department of Preventive Medicine, Shantou University Medical College) ;
  • Liu, Yan (Department of Preventive Medicine, Shantou University Medical College) ;
  • Zhu, Zhen-Li (Department of Preventive Medicine, Shantou University Medical College) ;
  • Huang, Yuan-Wei (Department of Preventive Medicine, Shantou University Medical College) ;
  • Li, Ke (Department of Preventive Medicine, Shantou University Medical College)
  • Published : 2016.09.01
⟨ Previous Next ⟩

Abstract

Background: Traditional meta-analyses or systematic reviews of randomized controlled trials (RCTs) have been used to compare laser surgeries and transurethral resection of the prostate (TURP) for benign prostate hyperplasia (BHP), but they cannot provide a hierarchy regarding efficacy and safety of treatment. Objective: We therefore performed a network meta-analysis (NMA) to compare and create hierarchies for efficacy and safety of TUPR and laser surgeries for BPH. Materials and Methods: We searched for reports of RCTs published up to April 25, 2015. After methodological quality assessment and data extraction, we performed an NMA to compare TURP and laser surgeries for BPH. Results: We ranked the treatments of TURP and laser surgeries for BPH. For IPSS at 6 months, holmium laser resection of the prostate (HoLRP) ranked the first-best and at 12 months, holmium laser enucleation of the prostate (HoLEP). For Qmax at 6 and 12 months, HoLEP ranked the first-best; for operative time it was TURP; for cathedral removal time, diode laser enucleation of the prostate (DiLEP) ranked the first-best. Conclusions: Although TURP is considered the gold standard for treating BPH, it is not better in terms of efficacy and safety compared with the laser surgery. Our NMA created hierarchies for the 9 types of surgery in terms of efficacy and safety, which should help clinicians choose the best approach for the individual patient.

Keywords

References

  1. Ades AE, Sculpher M, Sutton A, et al (2006). Bayesian methods for evidence synthesis in cost-effectiveness analysis. Pharmacoeconomics, 24, 1-19. https://doi.org/10.2165/00019053-200624010-00001
  2. Ahyaia SA, Kaplan SA, Kuntz RM, et al (2010). Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. European Urol, 58, 384-97. https://doi.org/10.1016/j.eururo.2010.06.005
  3. Al-Ansari A, Younes N, Sampige VP, et al (2010). GreenLight HPS 120-W Laser Vaporization Versus Transurethral Resection of the Prostate for Treatment of Benign Prostatic Hyperplasia: A Randomized Clinical Trial with Midterm Follow-up. Eur Urol, 58, 349-55. https://doi.org/10.1016/j.eururo.2010.05.026
  4. Bachmann A, Tubaro A, Barber N, et al (2014). 180-W XPS GreenLight Laser Vaporisation Versus Transurethral Resection of the Prostate for the Treatment of Benign Prostatic Obstruction: 6-Month Safety and Efficacy Results of a European Multicentre Randomised Trial-The GOLIATH Study. Eur Urol, 65, 931-42. https://doi.org/10.1016/j.eururo.2013.10.040
  5. Borenstein M, Hedges LV, Higgins JPT, et al (2010). A basic introduction to fixed-effect and random-effects models for meta-analysis. Research Synthesis Methods, 1, 97-111. https://doi.org/10.1002/jrsm.12
  6. Bouchier-Hayes DM, Anderson P, Van AS, et al (2006). KTP laser versus transurethral resection: early results of a randomized trial. J Endourol, 20, 580-5. https://doi.org/10.1089/end.2006.20.580
  7. Bouchier-Hayes DM, Appledorn SV, Bugeja P, et al (2010). A randomized trial of photoselective vaporization of the prostate using the 80-W potassium-titanyl-phosphate laser vs transurethral prostatectomy, with a 1-year follow-up. Bju International, 105, 964-9. https://doi.org/10.1111/j.1464-410X.2009.08961.x
  8. Capitan C, Blazquez C, Martin MD, et al (2011). Greenlight hps 120-w laser vaporization versus transurethral resection of the prostate for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: a randomized clinical trial with 2-year follow-up. Eur Urol, 60, 734-9. https://doi.org/10.1016/j.eururo.2011.05.043
  9. Committee APG (2003). AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations. J Urol, 170, 530-47. https://doi.org/10.1097/01.ju.0000078083.38675.79
  10. Cui D, Sun F, Zhuo J, et al (2013). A randomized trial comparing thulium laser resection to standard transurethral resection of the prostate for symptomatic benign prostatic hyperplasia: four-year follow-up results. World J Urol, 32, 1-7.
  11. Elmansy H, Baazeem A, Kotb A, et al (2012). Holmium Laser Enucleation Versus Photoselective Vaporization for Prostatic Adenoma Greater than 60 Ml: Preliminary Results of a Prospective, Randomized Clinical Trial. J Urol, 188, 216-21. https://doi.org/10.1016/j.juro.2012.02.2576
  12. Elshal AM, Elkoushy MA, El-Nahas AR, et al (2014). $GreenLight^{TM}$ Laser (XPS) Photoselective Vapo-Enucleation versus Holmium Laser Enucleation of the Prostate for the Treatment of Symptomatic Benign Prostatic Hyperplasia: A Randomized Controlled Study. J Urol, 193, 927-34.
  13. Elzayat EA, Al MMI (2009). Holmium laser ablation of the prostate versus photoselective vaporization of prostate 60 cc or less: short-term results of a prospective randomized trial. J Urol, 182, 133-8. https://doi.org/10.1016/j.juro.2009.02.117
  14. Elzayat EA, Habib EI, Elhilali MM (2005). Holmium laser enucleation of the prostate: A size-independent new "gold standard". Urol, 66, 108-13.
  15. Geavlete B, Multescu R, Dragutescu M, et al (2010). Transurethral resection (TUR) in saline plasma vaporization of the prostate vs standard TUR of the prostate: 'the better choice & rsquo; in benign prostatic hyperplasia? J Urol, 106, 1385.
  16. Gilling PJ, Mackey M, Cresswell M, et al (1999). Holmium laser versus transurethral resection of the prostate: a randomized prospective trial with 1-year followup. J Urol, 162, 1640-4. https://doi.org/10.1016/S0022-5347(05)68186-4
  17. Higgins, JPT (2008). Cochrane handbook for systematic reviews of interventions version 5.0. 2.
  18. Higgins JPT, Jackson D, Barrett JK, et al (2012). Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies. Research Synthesis Methods, 3, 98-110. https://doi.org/10.1002/jrsm.1044
  19. HIGGINS JPT, Whitehead A (1996). Borrowing strength from external trials in a meta-analysis. Statistics Med, 15, 2733-49. https://doi.org/10.1002/(SICI)1097-0258(19961230)15:24<2733::AID-SIM562>3.0.CO;2-0
  20. Horasanli K, Silay MS, Altay B, et al (2008). Photoselective potassium titanyl phosphate (KTP) laser vaporization versus transurethral resection of the prostate for prostates larger than 70 ml: a short-term prospective randomized trial. Urol, 71, 247-51. https://doi.org/10.1016/j.urology.2007.09.017
  21. Jansen JP, Crawford B, Bergman G, et al (2008). Bayesian Meta-Analysis of Multiple Treatment Comparisons: An Introduction to Mixed Treatment Comparisons. Value in Health, 11, 956-64. https://doi.org/10.1111/j.1524-4733.2008.00347.x
  22. Kuntz RM, Ahyai S, Lehrich K, et al (2004). Transurethral holmium laser enucleation of the prostate versus transurethral electrocautery resection of the prostate: a randomized prospective trial in 200 patients. J Urol, 172, 1012-6. https://doi.org/10.1097/01.ju.0000136218.11998.9e
  23. Lertakyamanee J, Ruksamanee EO, Tantiwong A, et al (2002). The risk and effectiveness of transurethral resection of prostate. J Med Associat Thailand = Chotmaihet thangphaet, 85, 1288-95.
  24. Li S, Zeng XT, Ruan XL, et al (2014). Holmium laser enucleation versus transurethral resection in patients with benign prostate hyperplasia: an updated systematic review with metaanalysis and trial sequential analysis. Plos One, 9, 101615. https://doi.org/10.1371/journal.pone.0101615
  25. Lu G, Ades AE (2004). Combination of direct and indirect evidence in mixed treatment comparisons. Statistics Med, 23, 3105-24. https://doi.org/10.1002/sim.1875
  26. Mamoulakis C, Rosette JJMCHdl, Ubbink DT (2010). Systematic review and meta-analysis of transurethral resection of the prostate versus minimally invasive procedures for the treatment of benign prostatic obstruction. Urol, 75, 1015-22. https://doi.org/10.1016/j.urology.2009.08.015
  27. Mavuduru RM, Mandal AK, Singh SK, et al (2009). Comparison of HoLEP and TURP in terms of efficacy in the early postoperative period and perioperative morbidity. Urologia Internationalis, 82, 130-5. https://doi.org/10.1159/000200786
  28. Mebust WK, Holtgrewe HL, Cockett ATK, et al (2002). Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol, 167, 999-1003. https://doi.org/10.1016/S0022-5347(02)80323-8
  29. Montorsi F, Naspro R, Salonia A, et al (2004). Holmium laser enucleation versus transurethral resection of the prostate: results from a 2-center, prospective, randomized trial in patients with obstructive benign prostatic hyperplasia. J Urol, 172, 1926-9. https://doi.org/10.1097/01.ju.0000140501.68841.a1
  30. Oesterling JE (1995). Benign prostatic hyperplasia. Medical and minimally invasive treatment options. New England J Med, 332, 99-109. https://doi.org/10.1056/NEJM199501123320207
  31. PhD PHCM, Chen CH, Kang CH, et al (2010). GreenLight HPS laser 120-W versus diode laser 200-W vaporization of the prostate: Comparative clinical experience. Lasers Surgery Med, 42, 624-9. https://doi.org/10.1002/lsm.20940
  32. Rassweiler J, Teber D, Kuntz R, et al (2006). Complications of Transurethral Resection of the Prostate (TURP)-Incidence, Management, and Prevention. Eur Urol, 50, 969-80. https://doi.org/10.1016/j.eururo.2005.12.042
  33. Razzaghi MR, Mazloomfard MM, Mokhtarpour H, et al (2014). Diode laser (980nm) vaporization in comparison with transurethral resection of the prostate for benign prostatic hyperplasia: randomized clinical trial with 2-year follow-up. Urol, 84, 526-32. https://doi.org/10.1016/j.urology.2014.05.027
  34. Rij SV, Gilling PJ (2012). In 2013, holmium laser enucleation of the prostate (HoLEP) may be the new 'gold standard'. Current Urology Reports, 13, 427-32. https://doi.org/10.1007/s11934-012-0279-4
  35. Roberts RO, Jacobsen SJ, Jacobson DJ, et al (1998). Natural history of prostatism: high American Urological Association Symptom scores among community-dwelling men and women with urinary incontinence. Urol, 51, 213-9. https://doi.org/10.1016/S0090-4295(97)00505-0
  36. Roehrborn CG, Mcconnell J, Bonilla J, et al (2000). Serum prostate specific antigen is a strong predictor of future prostate growth in men with benign prostatic hyperplasia. PROSCAR long-term efficacy and safety study. J Urol, 163, 13-20. https://doi.org/10.1016/S0022-5347(05)67962-1
  37. Salanti G, Ades AE, Ioannidis JPA (2011). Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial. J Clin Epidemiol, 64, 163-71. https://doi.org/10.1016/j.jclinepi.2010.03.016
  38. Salanti G, Higgins JP, Ades AE, et al (2008). Evaluation of networks of randomized trials. Statistical Methods Med Res, 17, 279-301. https://doi.org/10.1177/0962280207080643
  39. Schmid, Stewart CH, Rothstein GB, et al (2013). Software for Statistical Meta-analysis : Handbook of Meta-analysis in Ecology and Evolution.
  40. Shingleton WB, Terrell F, Renfroe DL, et al (1999). A randomized prospective study of laser ablation of the prostate versus transurethral resection of the prostate in men with benign prostatic hyperplasia. Urol, 54, 1017-21. https://doi.org/10.1016/S0090-4295(99)00319-2
  41. Sun N, Fu Y, Tian T, et al (2014). Holmium laser enucleation of the prostate versus transurethral resection of the prostate: a randomized clinical trial. Int Urol Nephrol, 46, 1277-82. https://doi.org/10.1007/s11255-014-0646-9
  42. Tan A, Liao C, Mo Z, et al (2007). Meta-analysis of holmium laser enucleation versus transurethral resection of the prostate for symptomatic prostatic obstruction. British Journal of Surgery, 94, 1201-8. https://doi.org/10.1002/bjs.5916
  43. Tan AHH, Gilling PJ, Kennett KM, et al (2003). A randomized trial comparing holmium laser enucleation of the prostate with transurethral resection of the prostate for the treatment of bladder outlet obstruction secondary to benign prostatic hyperplasia in large glands (40 to 200 Grams). J Urol, 170, 1270-4. https://doi.org/10.1097/01.ju.0000086948.55973.00
  44. Thangasamy IA, Chalasani V, Bachmann A, et al (2012). Photoselective vaporisation of the prostate using 80-w and 120-w laser versus transurethral resection of the prostate for benign prostatic hyperplasia: a systematic review with meta-analysis from 2002 to 2012. Eur Urol, 62, 315-23. https://doi.org/10.1016/j.eururo.2012.04.051
  45. Tugcu V, Tasci AI, Sahin S, et al (2008). Comparison of photoselective vaporization of the prostate and transurethral resection of the prostate: a prospective nonrandomized bicenter trial with 2-year follow-up. J Endourol, 22, 1519-25. https://doi.org/10.1089/end.2007.0321
  46. Westenberg A, Gilling P, Kennett K, et al (2004). Holmium laser resection of the prostate versus transurethral resection of the prostate: results of a randomized trial with 4-year minimum long-term followup. J Urol, 172, 616-9. https://doi.org/10.1097/01.ju.0000132739.57555.d8
  47. Xia SJ, Zhuo J, Sun XW, et al (2008). Thulium Laser versus Standard Transurethral Resection of the Prostate: A Randomized Prospective Trial. Eur Urol, 53, 382-89. https://doi.org/10.1016/j.eururo.2007.05.019
  48. Xue B, Zang Y, Zhang Y, et al (2013). GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: A prospective randomized trial. J X-Ray Sci Technol, 21, 125-32.
  49. Yan H, Ou TW, Chen L, et al (2013). Thulium laser vaporesection versus standard transurethral resection of the prostate: A randomized trial with transpulmonary thermodilution hemodynamic monitoring. Int J Urol, 20, 507-12. https://doi.org/10.1111/j.1442-2042.2012.03183.x
  50. Yang SS, Hsieh CH, Lee YS, et al (2012). Diode laser (980 nm) enucleation of the prostate: a promising alternative to transurethral resection of the prostate. Lasers Med Science, 28, 353-60.
  51. Zhang F, Shao Q, Herrmann TRW, et al (2012). Thulium laser versus holmium laser transurethral enucleation of the prostate: 18-month follow-up data of a single center. Urol, 79, 869-74. https://doi.org/10.1016/j.urology.2011.12.018
  52. Zhao CB, Ju-Cong LI, Yuan PQ, et al (2011). A meta-analysis of holmium laser enucleation of the prostate for benign prostatic hyperplasia. Zhonghua Nan Ke Xue = National J Andrology, 17, 1112-20.